A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

Journal: Science

Published: 2020-06-12

DOI: 10.1126/science.abc2241

Affiliations: 13

Authors: 25

Go to article
Institutions Share
Institute of Microbiology (IM), CAS, China 0.43
Shenzhen Third People's Hospital, SUSTech, China 0.15
Tianjin Institute of Industrial Biotechnology (TIB), CAS, China 0.09
Chinese Center for Disease Control and Prevention (China CDC), China 0.08
Capital Medical University, China 0.06
Laboratory Animal Center, China CDC, China 0.04
Institute for Laboratory Animal Resources, NIFDC, China 0.04
Beijing Institutes of Life Science (BIOLS), CAS, China 0.02
University of Science and Technology of China (USTC), China 0.02
China Agricultural University (CAU), China 0.02
Shanxi Academy of Advanced Research and Innovation (SAARI), China 0.02
University of Chinese Academy of Sciences (UCAS), China 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER